Content about Diabetes

February 1, 2013

A new study conducted by researchers at the University of Minnesota and nearby healthcare institutions shows that patients with diabetes experience better outcomes when they undergo face-to-face medication therapy management sessions with pharmacists.

Drug Store News has reported enough about the benefits of MTM to fill a book, but a scientific study showing a demonstrable benefit to it only makes the case stronger. It speaks to the growing role of the pharmacist as a key member of the patient's healthcare team, every bit as important as nurses and doctors, and also points to a role of growing importance to pharmacy retailers themselves as they seek to distinguish themselves in the marketplace.

A new study conducted by researchers at the University of Minnesota and nearby healthcare institutions shows that patients with diabetes experience better outcomes when they undergo face-to-face medication therapy management sessions with pharmacists.

January 31, 2013

A nutritional supplement may help ward off gestational diabetes in pregnant women, according to a new study.

NEW YORK — A nutritional supplement may help ward off gestational diabetes in pregnant women, according to a new study.

The study, conducted by researchers at Italy's University of Messina and published in the journal Diabetes Care, found that pregnant women with family histories of Type 2 diabetes who received myo-inositol saw a significant reduction in the incidence of gestational diabetes, a condition that causes high blood sugar in some pregnant women.

January 28, 2013

The Food and Drug Administration has approved three new drugs for Type 2 diabetes made by Takeda, the agency said.

SILVER SPRING, Md. — The Food and Drug Administration has approved three new drugs for Type 2 diabetes made by Takeda, the agency said Friday.

The FDA announced the approval of Nesina (alogliptin), Kazano (alogliptin and metformin) and Oseni (alogliptin and pioglitazone) tablets.

Alogliptin is a new active ingredient, while metformin and pioglitazone are drugs already on the market.

January 22, 2013

During its annual business review Tuesday, Johnson & Johnson announced that the recent introduction of the OneTouch Verio Glucose testing platform represented one of the first diabetes care devices to alert and display high/low patterns that deliver more meaningful and actionable insights to help patients better understand and manage their diabetes.

NEW YORK — During its annual business review Tuesday, Johnson & Johnson announced that the recent introduction of the OneTouch Verio Glucose testing platform represented one of the first diabetes care devices to alert and display high/low patterns that deliver more meaningful and actionable insights to help patients better understand and manage their diabetes.

January 11, 2013

A panel of Food and Drug Administration experts has recommended approval for an experimental Type 2 diabetes drug made by Johnson & Johnson, the drug maker said.

RARITAN, N.J. -- A panel of Food and Drug Administration experts has recommended approval for an experimental Type 2 diabetes drug made by Johnson & Johnson, the drug maker said.

J&J said the FDA's Endocrinologic and Metabolic Drugs Advisory Committee had recommended approval for canagliflozin, which the company plans to market under the name brand Invokana. The FDA is not required to follow the votes of advisory committees when deciding whether or not to approve a drug, but usually does.

January 8, 2013

iHealth Labs on Monday unveiled two new additions to its suite of devices — the iHealth Wireless Smart Gluco-Monitoring System and iHealth Pulse Oximeter — at the 2013 Consumer Electronics Show in Las Vegas.

LAS VEGAS — iHealth Labs on Monday unveiled two new additions to its suite of devices — the iHealth Wireless Smart Gluco-Monitoring System and iHealth Pulse Oximeter — at the 2013 Consumer Electronics Show here. 

January 4, 2013

Novo Nordisk has appointed Curtis Oltmans as its corporate VP and general counsel for legal and quality affairs, the company said Friday.

PRINCETON, N.J. — Novo Nordisk has appointed Curtis Oltmans as its corporate VP and general counsel for legal and quality affairs, the company said Friday.

In the new role, for which he will also join the company's U.S. executive team, Oltmans will be handle issues like law, quality, intellectual property, grants and philanthropy for the Danish drug maker's North American business.

December 17, 2012

Target has launched new products and a co-pay assistance program for customers with diabetes, the mass merchandise retailer said.

NEW YORK — Target has launched new products and a co-pay assistance program for customers with diabetes, the mass merchandise retailer said.

Target announced the release of new blood glucose meters and test strips. The retailer also offers products like alternative site lancets, alcohol prep pads and diabetic nutritional shakes.

The company also announced the launch of a $4 co-pay assistance program, as well as a free private-label blood glucose meter for customers who qualify for the program.

December 14, 2012

Diabetes patients at Kroger pharmacies who have private insurance can pay $4 for blood-glucose test strips, the supermarket operator said.

CINCINNATI — Diabetes patients at Kroger pharmacies who have private insurance can pay $4 for blood-glucose test strips, the supermarket operator said.

Kroger said insured patients could pay a $4 co-pay for Kroger Premium test strips. People with diabetes can spend as much as $1,000 per year out of pocket on test strips alone, Kroger said.

December 12, 2012

A subsidiary of Johnson & Johnson is seeking regulatory approval for a new Type 2 diabetes drug.

RARITAN, N.J. — A subsidiary of Johnson & Johnson is seeking regulatory approval for a new Type 2 diabetes drug.

J&J division Janssen Research & Development announced Wednesday that it had filed with the Food and Drug Administration for a drug combining the experimental drug canagliflozin and immediate-release metformin, a common generic drug for diabetes.

The company also submitted a regulatory approval application to the FDA for canagliflozin in May 2012.

December 5, 2012

Drug maker Novo Nordisk is creating what it calls the world's first all-diabetes professional cycling team, the company said.

BAGSVÆRD, Denmark — Drug maker Novo Nordisk is creating what it calls the world's first all-diabetes professional cycling team, the company said.

The Danish pharmaceutical manufacturer announced plans to create Team Novo Nordisk, a global team with more than 100 cyclists, triathletes and runners, all of whom have diabetes.

December 3, 2012

Women with ovarian cancer and diabetes who took the generic diabetes drug metformin showed better survival rates than those who did not take the drug, according to a new study led by the Mayo Clinic.

NEW YORK — Women with ovarian cancer and diabetes who took the generic diabetes drug metformin showed better survival rates than those who did not take the drug, according to a new study led by the Mayo Clinic.

The study, published in the journal Cancer, enrolled 61 patients who took metformin and 178 who didn't. Of those who took the drug, 67% were surviving after five years, compared with 47% of those who didn't take it. Further analysis indicated that patients taking metformin were almost four times likelier to survive than those not taking it.

December 3, 2012

Personal care company Naterra has announced the national launch of Phase+, a skin care line designed to address the cosmetic effects that diabetes has on the skin.

DALLAS — Personal care company Naterra has announced the national launch of Phase+, a skin care line designed to address the cosmetic effects that diabetes has on the skin. 

Phase+, which is now available at all Walgreens stores, is infused with anti-microbial ingredients to help prevent such skin care problems as cracked heels and ultra-dry skin from becoming a larger problem for diabetics, the company stated.    

November 29, 2012

Use of electronic health records 
improves medical outcomes among patients with diabetes, according to a recent study conducted by Kaiser Permanente.


Use of electronic health records 
improves medical outcomes among patients with diabetes, according to a recent study conducted by Kaiser Permanente.


November 28, 2012

Novo Nordisk has launched a mobile app for hemophilia patients, the drug maker said.

PRINCETON, N.J. — Novo Nordisk has launched a mobile app for hemophilia patients, the drug maker said.

HemaGo — available for iPhone, iPad and Android devices — is designed to track hemophilia treatment, bleeding episodes and life events, helping people with the condition and their caregivers monitor the details of treatment, including medications, dosing, bleeding information and the disease's effects on life events.

November 19, 2012

A study published last week by researchers from the University of California, San Diego School of Medicine has found a correlation between vitamin D3 serum levels and subsequent incidence of Type 1 diabetes.

SAN DIEGO — A study published last week by researchers from the University of California, San Diego School of Medicine has found a correlation between vitamin D3 serum levels and subsequent incidence of Type 1 diabetes. The six-year study of blood levels of nearly 2,000 individuals suggests a preventative role for vitamin D3 in this disease. The research appears the December issue of Diabetologia, a publication of the European Association for the Study of Diabetes.

November 16, 2012

People with diabetes in Cleveland enrolled in UnitedHealthcare employer-sponsored health plans can obtain free diabetes management services from Rite Aid, the retail pharmacy chain said Friday.

CLEVELAND — People with diabetes in Cleveland enrolled in UnitedHealthcare employer-sponsored health plans can obtain free diabetes management services from Rite Aid, the retail pharmacy chain said Friday.

The chain's pharmacists are participating in the Diabetes Control Program, part of UnitedHealth Group's Diabetes Prevention and Control Alliance, which is aimed at addressing the problem of Type 2 diabetes and prediabetes.

November 16, 2012

Walgreens and JDRF on Friday announced that Walgreens' community-based programs helped raise more than $1.3 million in 2012 for JDRF. The year marked the 21st anniversary of Walgreens' participation in JDRF's nationwide campaign to raise funds for research to put an end to diabetes.

NEW YORK — Walgreens and JDRF on Friday announced that Walgreens' community-based programs helped raise more than $1.3 million in 2012 for JDRF. The year marked the 21st anniversary of Walgreens' participation in JDRF's nationwide campaign to raise funds for research to put an end to diabetes.

During the month of July, as part of the Walgreens Way to Well Commitment, customers at more than 7,500 Walgreens stores could make donations of $1 or more at checkout. 

November 16, 2012

Walgreens and Take Care Clinics on Friday announced the offer of free health testing for hemoglobin A1C and blood glucose at more than 3,000 U.S. locations through the end of November as part of American Diabetes Month and the Walgreens Way to Well Commitment.

DEERFIELD, Ill. — Walgreens and Take Care Clinics on Friday announced the offer of free health testing for hemoglobin A1C and blood glucose at more than 3,000 U.S. locations through the end of November as part of American Diabetes Month and the Walgreens Way to Well Commitment. 

November 15, 2012

As more Americans join the ranks of diabetics, the opportunity to target these consumers at the shelf becomes more crucial. 


As more Americans join the ranks of diabetics, the opportunity to target these consumers at the shelf becomes more crucial. 


Retailers like Rite Aid are using pull-box displays that allow customers to physically handle a blood-glucose meter before they make that purchase decision. That kind of consumer engagement, evident throughout Rite Aid’s latest Wellness format store, for example, helps anchor diabetes as a front-end destination center. 


November 14, 2012

People with diabetes often develop clogged arteries that cause heart disease, and new research at Washington University School of Medicine in St. Louis suggests that low vitamin D levels are to blame.

ST. LOUIS — People with diabetes often develop clogged arteries that cause heart disease, and new research at Washington University School of Medicine in St. Louis suggests that low vitamin D levels are to blame. In a study published Nov. 9 in the Journal of Biological Chemistry, the researchers reported that blood vessels are less like to clog in people with diabetes who get adequate vitamin D. But in patients with insufficient vitamin D, immune cells bind to blood vessels near the heart, then trap cholesterol to block those blood vessels.

November 12, 2012

Cardinal Health on Monday announced the availability of free, downloadable materials to help community pharmacists educate patients about effective strategies for preventing and living with diabetes as part of National Diabetes Awareness Month.

DUBLIN, Ohio — Cardinal Health on Monday announced the availability of free, downloadable materials to help community pharmacists educate patients about effective strategies for preventing and living with diabetes as part of National Diabetes Awareness Month. 

November 9, 2012

A Food and Drug Administration panel has voted to support two experimental insulin treatments made by Novo Nordisk, the Danish drug maker said Thursday.

BAGSVÆRD, Denmark — A Food and Drug Administration panel has voted to support two experimental insulin treatments made by Novo Nordisk, the Danish drug maker said Thursday.

Novo Nordisk said the FDA's Endocrinologic and Metabolic Drugs Advisory Committee had voted 8-to-4 in favor of approval for insulin degludec and a combination treatment containing insulin degludec and insulin aspart.

November 9, 2012

Links Medical Products Animal Health Group on Thursday announced the introduction of their new Pet Gluco blood-glucose monitoring system for dogs and cats.

IRVINE, Calif. – Links Medical Products Animal Health Group on Thursday announced the introduction of their new Pet Gluco blood-glucose monitoring system for dogs and cats.

November 8, 2012

MinuteClinic is offering free diabetes screenings during November to mark Diabetes Month.

WOONSOCKET, R.I. — MinuteClinic is offering free diabetes screenings during November to mark Diabetes Month.